High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

Leukemia
F LauriaS Tura

Abstract

Flow cytometric expression of bcl-2 protein was analyzed in 90 newly diagnosed acute myeloblastic leukemia (AML) patients using an anti-bcl-2 monoclonal antibody by direct immunofluorescence technique and results were correlated with FAB cytotype, CD34 expression and clinical outcome. Bcl-2 was expressed in all AML cases with different intensity. The mean fluorescence index (MFI), expressed as the ratio of sample mean channel:control mean channel, ranged from 3.0 to 39.5 with a median value of 14. The MFI was significantly higher (P = 0.01) in M0 (20.9) and M1 (18.3) than in M2 (11.7), M3 (12.4), M4 (11.8) and M5 (9.5) cytotypes. In addition, bcl-2 MFI significantly correlated both with CD34 positivity (P = 0.001) and with CD34 MFI (P = 0.01), being CD34 antigen expressed in 65% of patients with a bcl-2 MFI >14, and only in 35% of AML cases with a bcl-2 MFI >14. When bcl-2 intensity expression was correlated with complete remission (CR) rate, a higher MFI was associated with a low CR rate after standard intensive chemotherapy. In particular, CR was achieved in 86% of patients with a bcl-2 MFI <14, but only in 57% of patients with a MFI >14 (P = 0.008). A further decrease of CR rate to 41% was observed in patients in whom a high...Continue Reading

Citations

Oct 17, 2006·Current Oncology Reports·Aaron D Schimmer
Aug 8, 2001·Leukemia Research·S T LeeY W Ko
May 15, 2002·Leukemia Research·Mariano P ScolnikEstella Matutes
Nov 25, 2000·British Journal of Haematology·C AdidaH Dombret
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Min H Kang, C Patrick Reynolds
May 18, 2012·Hematology Reports·Geetaram Sahu, Rabindra Kumar Jena
Mar 10, 2004·Expert Opinion on Biological Therapy·Faris Q B AlenziWaleed G Altamimi
Oct 27, 2015·Brain Tumor Pathology·Masaya NagaishiAkio Hyodo
Aug 24, 2010·Blood Cells, Molecules & Diseases·Mariana S GonzalezIrene B Larripa
Apr 10, 2008·International Journal of Cancer. Journal International Du Cancer·Isolda CasanovaRamon Mangues
Mar 30, 1999·Experimental Cell Research·M Jäättelä
Jul 26, 2016·Frontiers in Oncology·Leonardo Marques da FonsecaMárcia Alves Marques Capella
Aug 13, 2002·Hematology·Alexandra E IrvineYong-Lee Ong
Feb 3, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Simone BoehrerKai Uwe Chow
Aug 23, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·B D BenitesS T O Saad
Apr 13, 2004·Oncogene·Klaus-Michael Debatin, Peter H Krammer
Jan 29, 1999·Nature·P ten Dijke, C H Heldin
Jul 17, 1998·Nature·D R Evans, B A Hemmings

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.